AVX754

AVX754 · Avexa Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AVX754, covering 2011-06-23 to 2011-06-23. Get the full timeline:

Most recent: Clinical Trial Update: AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV [Phase 2]